Atherosclerosis and calcific aortic valve disease are common in the aged as well as in those with kidney disease, diabetes, and high cholesterol. Although cardiovascular calcification is a major pathological feature, calcific molecular mechanisms are poorly understood. High bone morphogenetic protein 2 (BMP2) levels and BMP signaling promote calcification. We sought to identify and restore mechanisms that restrain BMP signaling in healthy cardiovascular tissue. The 3' untranslated region (3'UTR) of the Bmp2 transcript restrains BMP2 synthesis in healthy aorta, valves, and vasculature by mechanisms that are conserved between rodents and humans. MicroRNAs (miRNAs) post-transcriptionally modulate gene expression via the 3'UTR and have clinical potential as biomarkers and therapeutic agents. Our goal is to elucidate the role of miRNAs during pathological calcification in the Klotho mouse model of kidney disease.
Introduction
The American Heart Association projects that 45% of Americans will have some form of heart and/or vascular disease by 2035 (1) . Calcification of blood vessels reduces their diameter and plasticity and ultimately promotes ischemic events (2) . Risk factors that promote both vascular and valvular calcification include aging, renal failure, and male sex; as well as hypercholesterolemia, smoking, and diabetes (3, 4) . An aging population and the epidemic of obesity ensure that cardiovascular disorders will be a major public health threat for decades to come. Understanding the signaling processes that regulate the behavior of vascular cells will reveal novel approaches to preventing and treating these devastating pathologies.
The molecular mechanisms underlying vascular calcification have been widely studied.
Abnormally elevated levels of the pro-osteogenic bone morphogenetic protein 2 (BMP2) and increased BMP signaling are implicated in all forms of pathological cardiovascular calcification. For example, BMP2 is synthesized in human atherosclerotic plaques (5) and calcified stenotic valves (6) . Moreover, BMP2 can induce master osteogenic factors such as RUNX2 in human aortic valve interstitial cells (7) and MSX2 in aortic smooth muscle cells (8) , induce calcification in vitro (7, (9) (10) (11) (12) , and cause ossification within adult diseased valves (12) (13) (14) and atherosclerotic plaques (5) . Forced synthesis of BMP2 in vascular smooth muscle cells accelerated atherosclerotic calcification in ApoE null mice fed a high cholesterol diet (15) . Genetic deficiency and pharmacological inactivation of BMP signaling reduced calcification not only in cultured cells (12, 16, 17) but also in Ldlr null mice fed a high-fat diet (18) , Mgp null mice (19) and Klotho mutant mice with renal failure (16) .
Given the importance of BMP2 and BMP signaling in cardiovascular calcification, identifying post-transcriptional regulators of BMP2 expression may provide new insights and targets for the treatment of cardiovascular disease. The 3'-untranslated region (3'-UTR) binds regulatory proteins and microRNAs (miRNAs) that influence polyadenylation, translation efficiency, and stability of mRNAs (20) . The length and extreme evolutionary conservation of the Bmp2 3'-UTR supports a major role for post-transcriptional regulation involving miRNAs (21) (22) (23) }. The goal of this study was to compare the profiles of miRNAs that modulate the synthesis of BMP2 and downstream BMP signaling proteins in the aorta of healthy mice relative to mice with pathologically calcified aorta.
Our mouse model is a Klotho hypomorph that causes dysregulated mineral metabolism (24) .
Mice homozygous for Klotho mutations have a short lifespan, growth retardation, osteoporosis, atherosclerosis, ectopic calcification, and renal disease. The KLOTHO protein, along with 1,25(OH)2 vitamin D3 and FGF23, tightly regulates phosphate homeostasis (25, 26) . Deficiency of KLOTHO leads to renal disease and subsequent hyperphosphatemia and ectopic calcification of soft tissues such as aorta, aortic valves and kidneys (16, 26) . Restoration of normal KLOTHO levels ameliorates calcification (25) . The dramatic calcification of the aorta and other tissues in Klotho mutant mice within 6-7 weeks of birth make them experimentally attractive for studying the regulation of the Bmp2 gene during pathological calcification. Furthermore, understanding the mechanism of aortic calcification in the context of kidney failure is important because 17% of the population over the age of 30 may suffer from this major cardiovascular disease risk factor by 2030 (1).
Our objective was to elucidate a comprehensive profile of miRNAs whose abundance is altered in the calcified aorta of Klotho homozygous mutant mice with renal disease. We also demonstrate that selected miRNAs can modulate the BMP2 ligand and proteins involved in BMP signaling and calcification in vivo. This study begins to fill a key gap in our understanding of post-transcriptional processes that control BMP signaling and calcification in vascular tissues and provides experimental support for miRNA replacement therapies in cardiovascular disease.
Materials and Methods

Tissue sample collection for microRNA microarray
Mice bearing the Klotho mutation were a gracious gift from Dr. Makoto Kuro-o (Jichi Medical University) by way of Dr. Sylvia Christakos (Rutgers New Jersey Medical School). The mice were a mixture of strains FVB, C57Bl/6J, and C3H/J. Because homozygous Klotho null mice are infertile, mice were maintained by heterozygous-byheterozygous mating. 25% of each litter was homozygous and exhibited the full Klotho phenotype, including ectopic soft tissue calcification. 50% were heterozygous and 25% were wild type. No statistically significant differences in any parameter were observed between mice bearing the heterozygous and wild type Klotho genotypes. Assessed parameters included the body and organ weights, gene expression, and calcium levels (27, 28) . Because our analyses were consistent with published data indicating that the Klotho mutation is fully recessive, heterozygous and wild type samples are presented together as "healthy control" samples. Immediately thereafter, the heart was perfused via the left ventricle with phosphate buffered saline (PBS, pH 7.3), to remove excess blood. The aorta including the ascending aorta, arch and descending thoracic aorta was removed. After cutting at the surface of the heart, the aorta was rinsed in PBS, blot dried and weighed. The aorta was snap-frozen in liquid nitrogen and stored at -80 • C. Frozen tissues were ground in liquid nitrogen using a mortar and pestle. RNA was extracted using the miRNeasy Mini Kit (Qiagen Inc., Germantown, MD, # 217004). The RNA quality was checked using Bioanalyzer (Agilent Technologies, Santa Clara, CA).
Calcium assays
Aorta tissues were ground in liquid nitrogen using a mortar and pestle and lysed by sonication on ice in PBS, pH 7.3, containing 0.16 mg/mL heparin. The Cayman Chemical Calcium Assay kit (Ann-Arbor, MI, #701220) was used to measure calcium levels. Calcium levels were normalized to protein levels measured using the Pierce BCA Protein Assay Kit (ThermoFisher Scientific, Waltham, MA, #23225).
MicroRNA microarray and data analysis
Aortic samples were obtained from both male and female control and Klotho mutant mice ( Table 1) Control (K+) 7-8 weeks 2 7-8 weeks 1
Klotho mutant (KK) 7-8 weeks 5 7-8 weeks 2
Biological process analyses 
MicroRNA-BMP signaling network analyses
The miRNAs that may affect the ligand BMP2 and the canonical signaling proteins SMAD1, 5, and 9 were determined using DIANA-micro T-CDS (v. 5.0), TargetScan (http://www.targetscan.org/vert_72/), and miRanda (31) computational prediction tools.
Our analyses were focused on the miRNAs that were down-regulated in Klotho mutant mice and predicted to affect the ligand BMP2 and the BMP-specific SMADs . Cytoscape software (32) was used to construct the interaction network between miRNAs and BMP signaling.
Real-Time PCR for detection of microRNA-145 and microRNA-378a and target gene expression
MicroRNA cDNA was synthesized using the miScript PCR Kit (Qiagen Inc., Germantown, MD, # 218073). The miScript PCR kit utilized a universal oligo-dT primer tag to convert all RNA species (total RNA and miRNA) into cDNA. A universal reverse primer supplied with the miScript PCR kit was used to amplify cDNA from each miRNA.
The miRNA forward primers were designed based on miRNA sequences in miRBase 22
(http://www.mirbase.org/). GCG or CGC was added to the 5' end of the primers when the GC % was low. NCBI nucleotide blast was used to confirm the absence of nonspecific binding sites for the forward primers. Messenger RNA (mRNA) cDNA was synthesized using the QuantiTect® Reverse Transcription kit (Qiagen Inc., Germantown, MD, # 205313). Intron-spanning primers for mRNA were used to eliminate amplicons generated from any contaminating genomic DNA. Primer sequences are shown in Table 2 . 
Statistical Analysis
Data are presented as mean ± SEM and analyzed with GraphPad (version 7; GraphPad Software Inc, La Jolla, CA). Statistical significance was assessed with either the Student's two-tailed t-test or ANOVA. Differences were considered significant at p<0.05.
Results
MicroRNA profiles differ in the aorta from Klotho mice
MicroRNAs are crucial regulators in cardiovascular pathologies (33) . Consequently, we hypothesized that miRNA profiles differ in aorta from healthy control mice and Klotho homozygous mutant mice with renal disease. BMP signaling and calcium levels are doubled in the aorta of Klotho homozygotes (27, 28) . To identify miRNAs involved in aortic calcification, we profiled miRNAs in aortas from control healthy and Klotho mutant mice. In total, 135 miRNAs were significantly increased and 77 miRNAs were significantly decreased in Klotho mutant homozygous males relative to control mice (p<0.05, Fig. 1ATable 3) . In Klotho mutant females, 62 miRNAs were significantly increased and 88 miRNAs were significantly decreased (p<0.05, Fig. 1B , Table 3 ).
These results are consistent with a major role for miRNA-mediated post-transcriptional regulation in aortic calcification. MicroRNAs influence many biological processes in vascular cells (33) . We hypothesized that miRNAs that are differentially expressed in the calcified aortas of Klotho mutant mice may affect processes related to osteogenesis. We used GO terms and the KEGG pathway to computationally predict the biological processes potentially regulated by the miRNAs whose abundance was altered in Klotho mice relative to control mice.
Consistent with a role in vascular calcification, biological processes relevant to osteogenic differentiation (4,34) such as skeletal development and the WNT and HIPPO signaling pathways were predicted to be targeted by the differentially regulated miRNAs ( Fig. 2A-D, Supporting Fig. 1A-D) .
Down-regulated miRNAs target BMP signaling
The BMP signaling pathway is essential for osteogenesis and vascular calcification (4, 34, 35) . BMP2 binds to the BMP receptor (BMPR), which phosphorylates and activates SMAD signaling. SMAD signaling increases transcription of RUNX2 and MSX2, leading to increased osteogenic differentiation (4, 34, 36) . We hypothesized that miRNAs that repress Bmp2 and Smad1, 5 and 9 might be down-regulated in the Klotho mice. Down-regulation of miRNAs that repress ligands and signaling mediators would partly account for the elevated BMP signaling observed in the Klotho aorta (27, 34) Fig. 3 ) and was predicted to target all four genes (Fig. 3) . Among the miRNAs down-regulated significantly in female Klotho mutant mice, miR-7235-3p and miR-7685-3p may target all four genes. The abundances of these two miRNAs were 76% and 84% of control levels, respectively (Supporting Table 1 ). The Cytoscape network showed that nine miRNAs were notable because they were significantly decreased in both male and female Klotho mutant mice and also may target Bmp2 and/or Smad1, 5, or 9. These were miR-182-5p, miR-30e-5p, miR-187-5p, miR-378a-5p, miR-3065-5p, miR-708-5p, miR-193a-3p, miR-193b-3p and miR-193b-5p (Table 4 ). We postulate that microRNAs that target more than one member of the BMP signaling pathway may inhibit BMP signaling by coordinately down-regulating multiple proteins and effectively restrain pathological calcification. MicroRNA-145 and microRNA-378a attenuation in Klotho mutant mice
We selected two microRNAs to test the principle that an miRNA targeting several members of the BMP signaling pathway would reduce KLOTHO deficiency-associated calcification. The vascular regulator miR-145a is predicted to target Bmp2, Smad1 and Smad5 ( Table 5 , (37)) and to improve atherosclerotic symptoms in a mouse model of hyperlipidemia (38) . Our microarray measurements showed that the abundance of miR-145a-5p was reduced by 25% in male Klotho mice as compared to healthy control mice ( Fig. 4A , Supporting Table 1 ). RT-PCR indicated that levels of both miR-145a-5p and -3p were signficantly reduced in Klotho mutant mice (Fig. 4B, D) . The experiments described below test the impact of increasing miR-145 abundance in the setting of kidney failure and accelerated aging.
The abundance of another microRNA predicted to target both Bmp2 and Smad5, miR-378a-5p, was sharply decreased in both male and female Klotho mutant mice (54% and 37% respectively, Fig. 4E ). The circulating level of miR-378 also was reduced in the plasma of patients with coronary heart disease (1) . Recent studies confirmed the expectation ( Table 5 ) that miR-378 directly regulates Bmp2 (39, 40) . RT-PCR validated our microarray results and confirmed that the abundance of miR-378a-5p in Klotho mutant mice was half that present in healthy control aorta from both sexes (Fig. 4F ). 
Forced overexpression of mir-145 and mir-378a levels in Klotho mutant mice
We used a vascular smooth muscle cell (VSMC)-specific mSm22a promoter-driven lentivirus to increase the abundance of miR-145 and miR-378a in the aortas of Klotho mutant homozygotes (Fig. 5A) . To evaluate the efficacies and persistence of lentiviral transduction, RT-PCR was used to test the aortic levels of miR-145 and miR-378a in mice injected with viruses bearing these miRNAs relative to empty virus vectors. The miR-145 virus raised miR-145a-5p and miR-145a-3p abundances by 1.4±0.8 and 2.0±0.01 fold, respectively, relative to empty virus (Fig. 5B, C) . Similarly, miR-378a-5p abundance increased by 1.7±0.04 fold (Fig. 5D ). Thus this delivery dosage and method successfully augmented aortic miR-145 and miR-378a levels in Klotho mutant mice.
Increased expression of miR-145 and miR-378a reduced BMP signaling and aortic calcification Three different proteins involved in BMP signaling: BMP2 and SMAD1 and 5 are predicted to be targeted by miR-145 (Table 5 ). Therefore, we hypothesized that increased miR-145 levels would repress the synthesis of these pro-osteogenesis factors and ameliorate pathological calcification. Having successfully augmented the level of miR-145 with lentivirus delivery, we evaluated the impact of this treatment on Bmp2 and Smad1 and 5 RNA levels with RT-PCR. The Bmp2 and Smad5 RNA levels in aortas from mice injected with miR-145-bearing virus fell to 48±0.03% and 65±0.006% (p =0.05) that of control aortas from mice injected with empty virus (Fig. 6A, C) . The miR-145 virus did not significantly change the abundances of the Smad1 RNA (Fig. 6B) .
To test if miR-145 overexpression inhibited pathological calcification in Klotho mice, we compared the calcium present in the aortas of Klotho mice injected with empty lentivirus vector or with virus bearing miR-145. The Klotho mice injected with the miR-145 virus had one third less aortic calcium as that observed in the empty virus injected mice (67±0.8%, p =0.002, Fig. 6 ). Thus, forced miR-145 expression limited pathological calcification in Klotho aorta.
The down-regulated miR-378a miRNA is predicted to target Bmp2 and Smad5 (Fig. 3,   4 ). To evaluate the potiential benefit of restoring miR-378a expression in the aorta of Klotho mutant mice, a lentivirus bearing miR-378a was injected. This virus reduced the levels of the target gene RNAs Bmp2 and Smad5 to 60±0.02% (p =0.02) and 64±0.4%
(p =0.04) respectively of the RNA levels observed in the mice injected with empty virus ( Fig. 7A and B ).
Finally we demonstrated that restoration of miR-378a abundance and the associated reduction in Bmp2 and Smad5 RNA abundances moderated aortic calcification.
Exposure to the mir-378a-bearing virus reduced aortic calcium levels by a third (63 ±0.6% of empty control, p=0.02) relative to levels in mice exposed to the empty virus ( Fig. 7C ). Thus as observed for miR-145, forced expression of miR-378a, significantly ameliorated pathological calcification of the aorta.
Discussion
Mice generally resist cardiovascular calcification. Genetic modifications that impact lipid or mineral metabolism or high fat/high cholesterol diets or surgical models of renal failure are required to adequately mimic atherosclerosis. Some of these models are experimentally time-consuming. For example, mice with genetically sensitized hyperlipidemia backgrounds must be fed special diets for months (41, 42) . In contrast,
Klotho mutant mice with hyperphosphatemia exhibit elevated BMP signaling and calcification in the aorta at 6-7 weeks of age. The swift pace of aortic calcification in the Klotho strain facilitates the testing of therapeutic approaches to reducing calcification.
Indeed, only 10 days of exposure to viruses bearing selected miRNAs caused a statistically significant reduction in aortic calcification (Fig. 4, 7) . Studies using Klotho mutant mice also are relevant to human biology, because KLOTHO deficiency is associated with human diseases involving soft tissue and vascular calcification such as chronic kidney disease (43) (44) (45) (46) .
We obtained and analyzed miRNA profiles in aortas from control healthy and Klotho homozygous mutant mice with renal impairment that causes aortic calcification. Our analyses of computationally predicted target genes and the biological processes these genes affect suggest that many regulated miRNAs influence osteogenic differentiation ( Fig. 2, Supporting Fig. 1 ). Notably, in both sexes, the biological process of skeletal development and the WNT and HIPPO signaling pathways were associated with the differentially regulated sets of genes. Along with BMP signaling, these pathways are closely involved in the osteogenic differentiation observed in both bones and in abnormally calcified soft tissues (3, 4) . Our discovery of common target profiles is consistent with the prevailing view that cardiovascular calcification proceeds by known bone formation pathways that have been ectopically activated by pathologies.
A large number of miRNAs that potentially regulate BMP signaling were identified within our profiles of differentially regulated miRNAs. We selected miR-145 and miR-378 to test the principle that miRNAs targeting several members of the BMP signaling pathway would reduce KLOTHO deficiency-associated calcification. Our gain-of-function approach, whereby a VSMC-targeted lentiviral vector bearing mir-145 or mir-378a was injected into Klotho mutant mice, raised the abundances of these miRNAs in mouse aorta relative to empty virus ( Fig. 5 ). Bmp2 and Smad5 RNA levels in aortas from mice injected with either virus fell significantly, indicating that these miRNAs could modulate BMP signaling (Fig. 6, 7) . Most importantly, Klotho mice injected with each miRNAbearing virus had one third lower aortic calcium relative to mice injected with empty virus (Fig. 6, 7) . Consistent with our results, forced overexpression of miR-145 decreased atherosclerotic plaque size, increased plaque stability, and promoted a contractile cell phenotype in the ApoE, high fat diet mouse model of hyperlipidemia (38) .
Our proof-of-principle experiments confirm that the strategy of manipulating miRNA levels in vivo can ameliorate the elevated BMP signaling and calcification associated with pro-calcific diseases.
In summary, we have provided a database of the miRNAs that are differentially expressed in healthy mouse aorta relative to aorta calcified due to defective mineral metabolism and kidney function. We also demonstrated that forced expression of miR-145 and miR-378 inhibited Bmp2 and Smad5 RNA levels. MiR-RNA-145 and miR-378 are candidates for translational studies investigating therapies to block vascular calcification. and target 1 or more of these protein-coding transcripts. Lentiviral delivery of the boldfaced, underlined RNAs has been shown to reduce calcification (Fig. 6, 7 ). Supporting Table 1 .
MicroRNA abundance in aorta from Klotho mutant homozygotes relative to healthy control. The percentage change for each miRNA whose abundance was significantly changed (p < 0.5) between Klotho homozygotes and control mice was calculated by the Partek Genomics Suite 7.0 (Partek Inc., St. Louis, MO).
